Kudriashov B A, Pastorova V E, Liapina L A, Kondashevskaia M V, Azieva L D, Sukhanov Iu S, Fedeniuk P V, Vasiukov S E, Cherstvova L G
Eksp Klin Farmakol. 1992 Jan-Feb;55(1):35-8.
Low-molecular heparin preparations (a Soviet sample and that manufactured by the Celsus Company) in vitro, added to bovine plasma possess a lower antifactor-II activity, less time of recalcification and partial thromboplastin time as compared to high-molecular heparin of equal concentration (mg/ml) or dose (Units/ml). After intravenous injection of low-molecular heparin preparations to animals in a dose of 50 Units/200 g bw the time of hemorrhage was far less, while anticoagulant activity was lower than in animals given the same dose of high-molecular heparin. Both injection of low-molecular and high-molecular heparin results in a rise of the intensity of non-enzymatic fibrinolysis in the animals' blood plasma.
低分子肝素制剂(一种苏联样品和塞尔苏斯公司生产的制剂)在体外添加到牛血浆中时,与同等浓度(毫克/毫升)或剂量(单位/毫升)的高分子肝素相比,具有较低的抗因子II活性、较短的复钙时间和部分凝血活酶时间。以50单位/200克体重的剂量给动物静脉注射低分子肝素制剂后,出血时间远短于注射同等剂量高分子肝素的动物,而抗凝活性则低于后者。注射低分子肝素和高分子肝素均会导致动物血浆中非酶促纤维蛋白溶解强度升高。